Series B - De Novo Pharmaceuticals - Jul 26, 2001 Funding Round Profile - Cointime

Bitcoin $94,236.87 -3.90%
Ethereum $3,420.02 +0.94%
BNB $640.78 -3.11%
Optimism $2.26 +2.76%
Arbitrum $0.91 +5.68%
Solana $236.59 -6.70%
Polygon $0.55 -1.69%
Cosmos $7.93 -7.89%
Avalanche $41.41 -0.93%

Bitcoin $94,236.87 -3.90%
Ethereum $3,420.02 +0.94%
BNB $640.78 -3.11%
Optimism $2.26 +2.76%
Arbitrum $0.91 +5.68%
Solana $236.59 -6.70%
Polygon $0.55 -1.69%
Cosmos $7.93 -7.89%
Avalanche $41.41 -0.93%

De Novo Pharmaceuticals

company

Funding Round

Series B

Money Raised

£ 16.75M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
Prelude Trust	-	-	-	Detail
FNI Venture Capital	-	-	-	Detail
The Cambridge Gateway Fund	-	-	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Apr 18, 2000	Series A	£ 2M	Prelude Trust	Detail